Skip to main content
. 2024 Nov 20;24:366. doi: 10.1186/s12893-024-02677-9

Table 4.

Comparison of surgical outcomes and primary diseases before/after 20 cases for PDAC, other malignant tumors, and benign or low-malignant diseases

Within 20 cases After 21 cases
PDAC Other malignant tumors Benign or low-malignant diseases p value PDAC Other malignant tumors Benign or low-malignant diseases p value
Number of pancreaticoduodenectomies 81 100 82 32 19 20
Age y, median (IQR) 70 (65-76) 71 (62-77) 66 (59-72) 0.003 72 (65-76) 74 (65-79) 66 (59-72) 0.022
Sex
 Female, n (%) 33 (41) 39 (39) 28 (34) 0.665 19 (59) 11 (58) 7 (35) 0.194
 Male, n (%) 48 (59) 61 (61) 54 (66) 13 (41) 8 (42) 13 (65)
BMI kg/m2 (IQR) 22 (20-25) 22 (21-24) 22 (21-25) 0.752 21 (19-23) 22 (21-25) 23 (22-24) 0.038
Preoperative biliary drainage yes, n (%) 42 (52) 64 (64) 2 (3) <0.001 21 (66) 14 (74) 1 (5) <0.001
Combined vascular resection yes, n (%) 31 (38) 7 (7) 2 (3) <0.001 14 (44) 0 (0) 0 (0) <0.001
Operative time min, median (IQR) 486 (430-544) 472 (410-532) 429 (378-477) <0.001 430 (397-494) 445 (375-471) 410 (337-458) 0.328
Blood loss ml, median (IQR) 500 (303-840) 502 (280-884) 355 (140-578) <0.001 345 (205-568) 400 (215-550) 315 (81-618) 0.642
Blood transfusion n (%) 9 (11) 18 (18) 3 (4) 0.010 1 (3) 1 (5) 0 (0) 0.089
Hospital deaths n (%) 4 (5) 0 (0) 0 (0) 0.010 0 (0) 0 (0) 1 (5) 0.274
Surgical complications of Clavien-Dindo ≥ IIIa
All 35 (43) 62 (62) 43 (52) 0.041 13 (41) 9 (47) 12 (60) 0.396
POPF ≥ grade B, n (%) 14 (17) 38 (38) 28 (4) 0.007 4 (3) 6 (32) 6 (30) 0.185
DGE, n (%) 8 (10) 7 (7) 6 (7) 0.750 4 (13) 2 (11) 2 (10) 0.955
SSI, n (%) 3 (4) 15 (15) 2 (2) 0.002 2 (6) 0 (0) 1 (5) 0.551
Bile leak, n (%) 2 (2) 4 (4) 5 (6) 0.509 1 (3) 0 (0) 1 (5) 0.634
Abdominal bleeding, n (%) 0 (0) 4 (4) 2 (2) 0.199 0 (0) 0 (0) 0 (0) 1.000
LOS days, median (IQR) 28 (18-389) 30 (24-41) 26 (20-35) 0.062 23 (17-32) 33 (6-41) 25 (18-33) 0.043

PDAC: Pancreatic Ductal Adenocarcinoma,

POPF: Postoperative Pancreatic Fistula, DGE: Delayed Gastric Emptying, SSI: Surgical Site Infection

LOS: Length Of Postoperative Hospital Stay